Journal of clinical psychopharmacologyHumansQuality of LifeKetamineDepressive DisorderTreatment-Resistant
Esketamine and Quality of Life Improvement in Treatment-Resistant Depression Patients: A Real-World Clinical Study.
Matteo Lupi, Alessandro Carano, Tiziano Acciavatti, Stefano Marini, Marco Palmucci, Elicio Marinucci, Enrico Paolini, Alessandro Gentile, Angelomarco Barioglio, Marco Giri, Domenico De Berardis, Giovanni Martinotti
Published: 202610.1097/JCP.0000000000002042
Abstract
PURPOSE: Treatment-resistant depression (TRD) is a common phenomenon and a considerable clinical challenge; recently, esketamine in conjunction with an oral antidepressant (AD) has emerged as a potential treatment for TRD. Several studies have shown…
Preview only. Read the full abstract at the source